|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl显示文摘 | WEISBERG E MANLEY PW BREITENSTEIN W | 2005 | Cancer Cell2005，7，2： | 1 |
| 2 | Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl显示文摘 | WEISBERG E MANLEY PW BREITENSTEIN W et ol | 2005 | Cancer Cell2005，7，2： | 1 |
| 3 | Mechanis- mus derdecarboxyl-ativen dimerisierung yon maleins:iureanhydrid zu dimethylmaleinsiureanhydrid unter einfluss yon 2-aminopyridin显示文摘 | BAUMANN M E BOSSHARD H BREITENSTEIN W | 1984 | H- elvetica Chimica Acta1984，67，7： | 1 |
| 4 | Herstellun- g yon disubstituierten maleins:ure-anhydriden mit hilfe yon reaktiven 2-oxo-3h-imidazopyridinium-verbindungen显示文摘 | BAUMANN M E BOSSHARD H BREITENSTEIN W | 1986 | Helvetica Chi- mica Acta1986，69，2： | 1 |
| 5 | Characterization of AMN107,a selective inhibitor of native and mutant Bcr-Abl显示文摘 | Weisberg E Manley PW Breitenstein W | 2005 | Cancer Cell2005，7，2： | 1 |
| 6 | Characterization of AMN107,a selective inhibitor of native and mutant Bcr-Abl显示文摘 | Weisberg E Manley PW Breitenstein W | 2005 | Cancer cell2005，7，2： | 1 |
| 7 | Characterization of AMN107,a Selective Inhibitor of Native and Mutant显示文摘 | Manley PW Breitenstein W | 2005 | Bcr-AbL Cancer Cell2005，7，12： | 1 |
| 8 | Characterization of AMN107,a selective inhibitor of native and mutant Bcr-Abl显示文摘 | Weisberg E Manley PW Breitenstein W | | 0，，02： | 1 |
| 9 | Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl 显示文摘 | Weisberg E Manley PW Breitenstein W | 2005 | Cancer Cell2005，7，2： | 1 |
| 10 | Charac terization of AMN107, a selective inhibitor of native and mutant Bcr-Abl显示文摘 | Weisberg E Manley PW Breitenstein W | 2005 | Canc Cell2005，7，4： | 1 |
| 11 | Urea derivatives of ST1571 as inhibitors of Bcr-Abl and PDGFR kinases显示文摘 | MANLEY P W BREITENSTEIN W BRuGGEN J | 2004 | Bioorg Med Chem Lett2004，14，： | 1 |
| 12 | Characterization of AMN107,a selective inhibitor of native and mutant Bcr-Abl显示文摘 | Weisberg E Manley P W Breitenstein W | 2005 | Cancer Cell2005，7，2： | 1 |
| 13 | Characterization of AMN107,a selective inhibitor of native and mutant bcr-abl 显示文摘 | Weisberg E Manley PW Breitenstein W | 2005 | Cancer Cell2005，7，2： | 1 |
| 14 | Assessment of hepatic steatosis by expert pathologists:the end of a gold standard显示文摘 | El-Badry AM Breitenstein S Jochum W | 2009 | Ann Surg2009，250，5： | 1 |
| 15 | Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl显示文摘 | WEISBERG E MANLEY PW BREITENSTEIN W | 2005 | Cancer Cell2005，7，2： | 1 |
| 16 | Urea derivatives of STI571 as inhibitors of Bcr-Abl and PDGFR kinases显示文摘 | Manley P W Breitenstein W Brtiggen J | 2004 | Bioorg Med Chem Lett2004，14，23： | 1 |
| 17 | Characte-rization of AMN107,a selective inhibitor of native andmutant Bcr-Abl显示文摘 | Weisberg E Manley PW Breitenstein W | 2005 | Cancer Cell2005，7，2： | 1 |
| 18 | Characterization of AMN107,a selective inhibitor of native and mutant Bcr-Abl显示文摘 | Weisberg E Manley PW Breitenstein W | 2005 | Cancer Cell2005，7，2： | 1 |
| 19 | Characterization of AMN107, a selective inhibitor of native and mutant bcr-abl 显示文摘 | WEISBERG E MANLEY P W BREITENSTEIN W | 2005 | Cancer Cell2005，7，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员